Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.
Journal: Breast cancer research : BCR
Published: August 29, 2019
Trastuzumab-Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition.
Journal: Molecular cancer therapeutics
Published: April 04, 2017
Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes.
Journal: Cancer immunology research
Published: September 24, 2015
PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers.
Journal: Breast cancer research and treatment
Published: January 18, 2015
Effect of niclosamide on basal-like breast cancers.
Journal: Molecular cancer therapeutics
Published: February 21, 2014
Recurrent read-through fusion transcripts in breast cancer.
Journal: Breast cancer research and treatment
Published: November 04, 2013
Phase I study of a modified regimen of ⁹⁰Yttrium-ibritumomab tiuxetan for relapsed or refractory follicular or transformed CD20+ non-Hodgkin lymphoma.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: March 28, 2013
HER2 overexpression renders human breast cancers sensitive to PARP inhibition independently of any defect in homologous recombination DNA repair.
Journal: Cancer research
Published: September 19, 2012
Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma.
Journal: Leukemia & lymphoma
Published: July 11, 2012
Predictors of long-term outcome from intraperitoneal radioimmunotherapy for ovarian cancer.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: January 14, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026